[{"Assets_0_FY_USD":593795000.0,"CommonStockSharesOutstanding_0_FY_shares":71115000.0,"EarningsPerShareBasic_1_FY_USD":-2.14,"EarningsPerShareBasic_4_FY_USD":-11.89,"EarningsPerShareDiluted_1_FY_USD":-2.14,"EarningsPerShareDiluted_4_FY_USD":-11.89,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-635639000.0,"NetIncomeLoss_1_FY_USD":-155052000.0,"NetIncomeLoss_4_FY_USD":-819378000.0,"Revenues_1_FY_USD":1606000.0,"Revenues_4_FY_USD":3662000.0,"StockholdersEquity_0_FY_USD":374277000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20220304"}]